Global Animal Stem Cell Therapy Market Key Vendor Analysis 2022

Posted by sandeep gade on December 20th, 2022

he global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).

Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that are given to animals. Hematopoietic stem cells and mesenchymal stem cells are used in these treatment procedures.

As the focus on giving animals a better quality of life grows, so does the adoption of such therapies across the world. The market for animal stem cell therapy is predicted to continuously increase owing to the growing need for higher levels of veterinary care.

Regulatory bodies are also encouraging veterinary regenerative medicine research & development.

The Veterinary Innovation Program, for example, fosters breakthroughs in the field of animal products such as animal cells, tissues, and cell- and tissue-based products. It aids in the streamlining of such products' regulatory activities.

The European Commission has approved a few stem cell-based products within the region.

For example, Boehringer Ingelheim has obtained approval for its Arti-Cell® Forte, which is a stem cell-based product for the treatment of lameness in horses.

The animal stem cell therapy market is moderately fragmented with a few key market players and presents numerous opportunities for new market entrants to create a foothold in the industry. Increased pet adoption rate can be a beneficial factor for manufacturers of stem cells to expand into emerging markets.

Buy Full Report Now and Get Up to 20% Discount:

Top Reports: Hearing Aids MarketWound Healing Assessment MarketCar T Cell Therapy Market

Like it? Share it!

sandeep gade

About the Author

sandeep gade
Joined: August 22nd, 2022
Articles Posted: 835

More by this author